US mesothelioma patterns 1973–2002: indicators of change and insights into background rates

Mesothelioma rates are declining toward background levels, although estimates of the background rate have varied. We expanded upon earlier analyses and provided a data-based estimate of the background rate. We analyzed US male and female patterns for five age groups using the National Cancer Institute's Surveillance Epidemiology and End Results registry data from 1973 to 2002. Age-specific and age-adjusted incidence rates per 1 000 000 persons per year, standardized to the 2000 US population, were calculated for total, pleural, and peritoneal mesothelioma. We also calculated rates for persons who attained working age after the US Occupational Safety and Health Administration asbestos exposure limits took effect. Mesothelioma rates observed among young males and females varied little over time. We observed a decline and convergence of recent male and female rates in older age groups, except those who are between the age of 60 and above, for whom the 2002 male rate was approximately five times greater than that of females. As expected, rates were higher in major shipyard areas on the West coast. Rates for persons with little or no opportunity for occupational asbestos exposure were 1.15 (95% confidence interval: 0.90–1.45) for men and 0.94 (95% confidence interval: 0.87–1.24) for women. Mesothelioma is rare in younger age groups, and rates have been relatively stable and similar for both sexes. Rates continue to decline in older age groups, but remain high for males at 60 years or older. Rates among females at older ages suggest an impact of occupational exposure. The background rate for persons below age 50 is approximately one per million, independent of sex. Future data are needed to estimate this rate for older age groups.

[1]  E. Lau,et al.  Therapeutic radiation for lymphoma , 2007, Cancer.

[2]  C. Cardinez,et al.  United States cancer statistics; 2003 incidence and mortality , 2006 .

[3]  A. Oshima,et al.  Incidence and survival of mesothelioma in Osaka, Japan. , 2006, Japanese journal of clinical oncology.

[4]  V. Rusch,et al.  Malignant mesothelioma in Australia , 2006 .

[5]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[6]  Ken Takahashi,et al.  Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. , 2006, American journal of industrial medicine.

[7]  Denis H. Rushworth The Navy and Asbestos Thermal Insulation , 2005 .

[8]  M. Price,et al.  Mesothelioma mortality in Great Britain from 1968 to 2001. , 2005, Occupational medicine.

[9]  A. Churg,et al.  Changing trends in US mesothelioma incidence , 2004, Occupational and Environmental Medicine.

[10]  Bertram Price,et al.  Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. , 2004, American journal of epidemiology.

[11]  A. Polednak Geographic distribution of incident mesothelioma in Connecticut men, 1990–99 , 2003, International journal of cancer.

[12]  A. Andersen,et al.  Incidence trends of mesothelioma in Norway, 1965–1999 , 2003, International journal of cancer.

[13]  Manfred Neuberger,et al.  Three decades of pleural cancer and mesothelioma registration in Austria where asbestos cement was invented , 2003, International archives of occupational and environmental health.

[14]  Michael Huncharek,et al.  Non-asbestos related diffuse malignant mesothelioma. , 2002, Tumori.

[15]  J. Leigh,et al.  Malignant mesothelioma in Australia, 1945-2000. , 2002, American journal of industrial medicine.

[16]  K. McPherson,et al.  H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[17]  C. la Vecchia,et al.  An age, period and cohort analysis of pleural cancer mortality in Europe. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[18]  B. Hankey,et al.  The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  G. Hillerdal Mesothelioma: cases associated with non-occupational and low dose exposures. , 1999, Occupational and environmental medicine.

[20]  F Levi,et al.  The European mesothelioma epidemic , 1999, British Journal of Cancer.

[21]  C. Bianchi,et al.  Latency periods in asbestos-related mesothelioma of the pleura. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  B. Price Analysis of current trends in United States mesothelioma incidence. , 1997, American journal of epidemiology.

[23]  J. Benichou,et al.  Malignant mesothelioma: attributable risk of asbestos exposure. , 1994, Occupational and environmental medicine.

[24]  M. Jaurand,et al.  The Mesothelial Cell and Mesothelioma , 1994 .

[25]  B. Lanphear,et al.  Latent period for malignant mesothelioma of occupational origin. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[26]  J. Wagner,et al.  Background incidence of mesothelioma: animal and human evidence. , 1991, Regulatory toxicology and pharmacology : RTP.

[27]  J M Peters,et al.  Recent trends in mesothelioma incidence in the United States. , 1986, American journal of industrial medicine.

[28]  J. Mcdonald,et al.  Health implications of environmental exposure to asbestos. , 1985, Environmental health perspectives.

[29]  A. Musk,et al.  Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia , 1985, The Medical journal of Australia.

[30]  A. D. McDonald,et al.  Mesothelioma and asbestos fibre type. , 1985, British journal of industrial medicine.

[31]  W. Rom,et al.  TRENDS IN MORTALITY OF DIFFUSE MALIGNANT MESOTHELIOMA OF PLEURA , 1983, The Lancet.

[32]  N. Dreyer,et al.  Projections of asbestos-related disease 1980-2009. , 1983, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[33]  K. Rothman,et al.  Epidemiologic Analysis with a Programmable Calculator , 1982 .

[34]  I. Selikoff,et al.  Occupational exposure to asbestos: population at risk and projected mortality--1980-2030. , 1982, American journal of industrial medicine.

[35]  A. D. McDonald,et al.  Malignant mesothelioma in North America , 1980, Cancer.

[36]  J. Fraumeni,et al.  Cancer mortality in U.S. counties with shipyard industries during World War II. , 1979, Environmental research.

[37]  R. Doll Cancer in Five Continents , 1972, Proceedings of the Royal Society of Medicine.

[38]  A. Berger FUNDAMENTALS OF BIOSTATISTICS , 1969 .

[39]  T. Miller Late results in peptic ulcer. , 1947, The American journal of medicine.

[40]  F. J. Viles,et al.  A health survey of pipe covering operations in constructing naval vessels. , 1946, The Journal of industrial hygiene and toxicology.